Related Experiment Videos
Familial Parkinson's point mutation abolishes multiple system atrophy prion replication
Amanda L Woerman1,2, Sabeen A Kazmi1, Smita Patel1
1Institute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California, San Francisco, CA 94158.
Abstract:
In the neurodegenerative disease multiple system atrophy (MSA), α-synuclein misfolds into a self-templating conformation to become a prion. To compare the biological activity of α-synuclein prions in MSA and Parkinson's disease (PD), we developed nine α-synuclein-YFP cell lines expressing point mutations responsible for inherited PD. MSA prions robustly infected wild-type, A30P, and A53T α-synuclein-YFP cells, but they were unable to replicate in cells expressing the E46K mutation. Coexpression of the A53T and E46K mutations was unable to rescue MSA prion infection in vitro, establishing that MSA α-synuclein prions are conformationally distinct from the misfolded α-synuclein in PD patients. This observation may have profound implications for developing treatments for neurodegenerative diseases.
Insights
Multiple system atrophy (MSA) and Parkinson's disease (PD) involve misfolded alpha-synuclein. MSA prions infect cells except those with the E46K mutation, indicating distinct conformations and potential therapeutic targets.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by the misfolding of alpha-synuclein into a prion form.
- Parkinson's disease (PD) also involves alpha-synuclein pathology, with specific genetic mutations linked to inherited forms of the disease.
Purpose of the Study:
- To compare the biological activity of alpha-synuclein prions in MSA with those associated with Parkinson's disease.
- To investigate the role of specific alpha-synuclein mutations in prion replication and conformational differences.
Main Methods:
- Development of nine alpha-synuclein-YFP cell lines expressing point mutations associated with inherited PD.
- Infection of these cell lines with MSA prions to assess replication efficiency.
- Evaluation of prion replication in wild-type, A30P, A53T, and E46K mutant alpha-synuclein-YFP cells, as well as coexpression models.
Main Results:
- MSA prions robustly infected wild-type, A30P, and A53T alpha-synuclein-YFP cells.
- Replication of MSA prions was completely inhibited in cells expressing the E46K mutation.
- Coexpression of A53T and E46K mutations did not rescue MSA prion infection, confirming distinct conformational properties.
Conclusions:
- MSA alpha-synuclein prions exhibit distinct conformational properties compared to misfolded alpha-synuclein found in Parkinson's disease.
- The E46K mutation confers resistance to MSA prion infection, highlighting its unique structural characteristics.
- These findings have significant implications for understanding disease mechanisms and developing targeted therapies for neurodegenerative diseases like MSA and PD.